Cargando…
New Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
Malignant melanoma (MM) is the most lethal skin cancer. Despite a 4% reduction in mortality over the past few years, an increasing number of new diagnosed cases appear each year. Long-term therapy and the development of resistance to the drugs used drive the search for more and more new agents with...
Autores principales: | Kozyra, Paweł, Krasowska, Danuta, Pitucha, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180979/ https://www.ncbi.nlm.nih.gov/pubmed/35682764 http://dx.doi.org/10.3390/ijms23116084 |
Ejemplares similares
-
Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold—A Short Review of Most Recent Studies 2013–2022
por: Kozyra, Paweł, et al.
Publicado: (2022) -
Potential Anticancer Agents against Melanoma Cells Based on an As-Synthesized Thiosemicarbazide Derivative
por: Kozyra, Paweł, et al.
Publicado: (2022) -
2,4-Dichlorophenoxyacetic Thiosemicarbazides as a New Class of Compounds against Stomach Cancer Potentially Intercalating with DNA †
por: Pitucha, Monika, et al.
Publicado: (2020) -
Retention Behavior of Anticancer Thiosemicarbazides in Biomimetic Chromatographic Systems and In Silico Calculations
por: Studziński, Marek, et al.
Publicado: (2023) -
Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
por: Hou, Jing-Zhou, et al.
Publicado: (2021)